ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹179 Cr | ₹153 Cr | ₹161 Cr | ₹131 Cr | ₹139 Cr |
What is the latest Total Current Liabilities ratio of ANUH PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹179 Cr |
| Mar2024 | ₹153 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹131 Cr |
| Mar2021 | ₹139 Cr |
How is Total Current Liabilities of ANUH PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹179 Cr | 16.91 | |
| Mar2024 | ₹153 Cr | -5.36 | |
| Mar2023 | ₹161 Cr | 23.24 | |
| Mar2022 | ₹131 Cr | -6.14 | |
| Mar2021 | ₹139 Cr | - | |
Compare Total Current Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹756.5 Cr | -1.7% | -8.1% | -3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -1.7% |
-8.1% |
-3.9% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses